The study found:
• In patients undergoing both decompression and fusion, one-year readmission rate was 9.7 percent and two-year readmission rate was 14.6 percent.
• In patients only undergoing decompression, one- year readmission was 7.2 percent and two-year readmission rate was 12.5 percent.
• Of readmitted patients, including both fusion and non-fusion cohorts, 22 percent received pain management injection, 23 percent decompression and 56 percent fusion.
• In patients that were not readmitted, 25 percent received outpatient pain management injections within the three months following their surgery.
• Overall, spinal stenosis decompression readmission rates were found to be 8 to 10 percent per year.
The study ultimately concluded that fusion does not influence readmission rates.
More Articles on Spine:
10 Big Healthcare Policy Trends for Spine Surgeons to Know
Orthopaedic & Spine Institute Establishes Children’s Ward
Dr. Richard Spiro, Michael Horowitz Join PA Brain and Spine
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
